Armenia-US Collaboration to Address Chronic Disease via Education in Social Determinants Science (ACCESS)

亚美尼亚与美国合作通过社会决定因素科学教育解决慢性病问题 (ACCESS)

基本信息

  • 批准号:
    10664096
  • 负责人:
  • 金额:
    $ 24.44万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-04-01 至 2028-02-29
  • 项目状态:
    未结题

项目摘要

SUMMARY/ABSTRACT The COVID-19 pandemic heightened awareness of health disparities and related social determinants (SDs) globally, as well as inequalities in countries’ capacities to study and address such disparities and their SDs. This is especially relevant to non-communicable diseases (NCDs), which account for >70% of deaths annually and disproportionately impact low- and middle-income countries (LMICs). Armenia (AM) faces particular NCD- related challenges; NCDs account for 93% of all deaths and the top 10 causes of death, premature death, and disability. Critical to decreasing NCD burden is reducing modifiable NCD risk factors (e.g., tobacco/alcohol use, unhealthy diet); this is particularly important in AM. AM has the 11th highest male smoking rate globally (52%), ranks in the top 40% of countries in alcoholism rates, and has a 48% prevalence of overweight/obesity. SDs (e.g., healthcare, social context) impact both modifiable NCD risk factors and NCD outcomes, and play a crucial role in NCD-related health disparities in AM. We propose the Armenia-US Collaboration to Address Chronic Disease via Education in Social Determinants Science (ACCESS) program, in response to PAR- 21-230. Its overall goal is to reduce the NCD burden in AM by enhancing research capacity related to NCD prevention and control, emphasizing SDs of NCD risk factors as key components. ACCESS is a strategic collaboration between George Washington University (GW) and American University of Armenia (AUA), alongside AM’s Ministry of Health (MOH) and its entities (e.g., NIH). Leveraging our team’s substantial ongoing collaborations, ACCESS will be an effective, sustainable program that enhances research infrastructure, training, and research opportunities related to NCD prevention and control for junior researchers. In Aim 1, we will develop a formal NCD prevention and control research training program (emphasizing SDs of NCD risk factors) and related institutional infrastructure. We will offer specialized training to: a) long-term MPH trainees who already hold an MD or related doctoral degree in order to develop future NCD research leaders; and b) short-term trainees (e.g., public health/clinical students/professionals) to enhance core NCD research skills. In Aim 2, we will advance AM’s national NCD research agenda via mentored research focused on SDs of NCD risk factors among future NCD research leaders (i.e., long-term trainees). In Aim 3, we will catalyze NCD- related research dissemination and knowledge translation to inform policy and practice, by enhancing related skills and leveraging the engagement of the MOH and its entities. ACCESS will be the 1st program of its kind in AM and will address AM’s national health priorities. We will establish future NCD prevention and control leaders and an educational core for the broader community of public health and clinical professionals in AM. Our team is uniquely-suited to establish ACCESS, enhance NCD research capacity in AM in the next 5 years, and sustain and expand it in scope and scale in the long-term to optimize its impact on global NCD burden.
总结/摘要 2019冠状病毒病大流行提高了人们对健康差距和相关社会决定因素的认识。 在全球范围内,以及各国研究和解决这种差距及其可持续发展能力的不平等。 这与非传染性疾病尤其相关,每年非传染性疾病造成的死亡人数超过70 并对低收入和中等收入国家(LMIC)造成不成比例的影响。亚美尼亚(AM)面临着特殊的非传染性疾病- 非传染性疾病占所有死亡人数的93%,是导致死亡、过早死亡和 残疾。减少非传染性疾病负担的关键是减少可改变的非传染性疾病风险因素(例如,吸烟/饮酒, 不健康的饮食);这在AM中尤其重要。AM的男性吸烟率在全球排名第11位(52%), 在酗酒率排名前40%的国家中,超重/肥胖率为48%。SDS (e.g.,医疗保健,社会背景)影响可改变的NCD风险因素和NCD结果,并发挥 在AM中与NCD相关的健康差异中起关键作用。我们建议亚美尼亚-美国合作解决 慢性疾病通过教育在社会决定因素科学(访问)计划,在回应PAR- 21-230.其总体目标是通过提高与非传染性疾病相关的研究能力, 预防和控制,强调非传染性疾病危险因素的SD作为关键组成部分。Access是一种战略 乔治华盛顿大学(GW)和亚美尼亚美国大学(AUA)之间的合作, 与AM的卫生部(MOH)及其实体(例如,NIH)。利用我们团队持续不断的 合作,ACCESS将是一个有效的,可持续的计划,加强研究基础设施, 为初级研究人员提供与NCD预防和控制相关的培训和研究机会。目标1: 将制定正式的NCD预防和控制研究培训计划(强调NCD风险的SD (三)相关的基础设施建设。我们将为以下人员提供专门培训:a)长期MPH学员 已经拥有医学博士或相关博士学位,以培养未来的NCD研究领导者;以及B) 短期受训人员(例如,公共卫生/临床学生/专业人员),以提高核心非传染性疾病研究技能。在 目标2,我们将通过重点关注非传染性疾病可持续发展的指导性研究,推进AM的国家非传染性疾病研究议程 未来NCD研究领导者的风险因素(即,长期实习生)。在目标3中,我们将催化NCD- 通过加强相关研究传播和知识转化,为政策和实践提供信息 技能和利用卫生部及其实体的参与。Access将成为2013年同类项目中的第一个 AM将解决AM的国家卫生优先事项。我们将建立未来的非传染性疾病预防和控制 领导者和教育核心,为更广泛的社区公共卫生和临床专业人员在上午。 我们的团队非常适合在未来5年内建立ACCESS,提高AM的NCD研究能力, 并长期维持和扩大其范围和规模,以优化其对全球NCD负担的影响。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Carla J Berg其他文献

Types and Brands of Derived Psychoactive Cannabis Products: An Online Retail Assessment, 2023.
精神活性大麻衍生产品的类型和品牌:在线零售评估,2023 年。
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    3.8
  • 作者:
    M. Rossheim;Kayla K Tillett;Viktor. Vasilev;C. LoParco;Carla J Berg;P. Trangenstein;R. Yockey;Steven Y Sussman;Michael B. Siegel;David H. Jernigan
  • 通讯作者:
    David H. Jernigan
Derived psychoactive cannabis products and 4/20 specials: An assessment of popular brands and retail price discounts in Fort Worth, Texas, 2023.
衍生精神活性大麻产品和 4/20 特价商品:对 2023 年德克萨斯州沃斯堡流行品牌和零售价格折扣的评估。
  • DOI:
    10.1016/j.drugalcdep.2024.111119
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    4.2
  • 作者:
    M. Rossheim;C. LoParco;Carla J Berg;Kayla K. Tillett;P. Trangenstein;Doug Henry;R. Yockey;M. D. Livingston;David H. Jernigan;Steven Y. Sussman
  • 通讯作者:
    Steven Y. Sussman

Carla J Berg的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Carla J Berg', 18)}}的其他基金

Effects of State Preemption of Local Tobacco Control Legislation on Disparities in Tobacco Use, Exposure and Retail
国家抢先实施地方烟草控制立法对烟草使用、接触和零售差异的影响
  • 批准号:
    10681733
  • 财政年份:
    2023
  • 资助金额:
    $ 24.44万
  • 项目类别:
Implementing a Scalable Smoke-free Home Intervention in Armenia and Georgia
在亚美尼亚和格鲁吉亚实施可扩展的无烟家庭干预措施
  • 批准号:
    10607033
  • 财政年份:
    2023
  • 资助金额:
    $ 24.44万
  • 项目类别:
Recreational Marijuana Marketing and Young Adult Consumer Behavior
休闲大麻营销和年轻成人消费者行为
  • 批准号:
    10597218
  • 财政年份:
    2022
  • 资助金额:
    $ 24.44万
  • 项目类别:
Recreational Marijuana Marketing and Young Adult Consumer Behavior - Administrative Supplement
休闲大麻营销和年轻成人消费者行为 - 行政补充
  • 批准号:
    10848546
  • 财政年份:
    2022
  • 资助金额:
    $ 24.44万
  • 项目类别:
Regulatory Impact on Vape Shops and Young Adults' Use of ENDS
监管对电子烟商店和年轻人使用 ENDS 的影响
  • 批准号:
    10310412
  • 财政年份:
    2019
  • 资助金额:
    $ 24.44万
  • 项目类别:
Emory-Georgia Clean Air Research & Education (CARE) Program
埃默里-佐治亚州清洁空气研究
  • 批准号:
    10017980
  • 财政年份:
    2019
  • 资助金额:
    $ 24.44万
  • 项目类别:
Assessing IQOS Marketing Influences and Consumer Behavior in Israel: Implications for the US
评估 IQOS 在以色列的营销影响和消费者行为:对美国的影响
  • 批准号:
    10246189
  • 财政年份:
    2019
  • 资助金额:
    $ 24.44万
  • 项目类别:
Regulatory Impact on Vape Shops and Young Adults' Use of ENDS
监管对电子烟商店和年轻人使用 ENDS 的影响
  • 批准号:
    10524237
  • 财政年份:
    2019
  • 资助金额:
    $ 24.44万
  • 项目类别:
Assessing IQOS Marketing Influences and Consumer Behavior in Israel: Implications for the US
评估 IQOS 在以色列的营销影响和消费者行为:对美国的影响
  • 批准号:
    10020369
  • 财政年份:
    2019
  • 资助金额:
    $ 24.44万
  • 项目类别:
Smoke-free Air Coalitions in Georgia and Armenia: A Community Randomized Trial
格鲁吉亚和亚美尼亚的无烟空气联盟:社区随机试验
  • 批准号:
    9372431
  • 财政年份:
    2017
  • 资助金额:
    $ 24.44万
  • 项目类别:

相似海外基金

The investigation of chronic alcohol consumption enhanced aging colon in elder mice and the mechanism of suppressed on aging colon tissues by sesame lignans continuous intake
长期饮酒促进老年小鼠结肠衰老的研究及持续摄入芝麻木脂素抑制结肠组织衰老的机制
  • 批准号:
    23K10904
  • 财政年份:
    2023
  • 资助金额:
    $ 24.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of carcinogenesis and symptoms associated with alcohol consumption
致癌的分子机制和饮酒相关症状
  • 批准号:
    23K05734
  • 财政年份:
    2023
  • 资助金额:
    $ 24.44万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Internal Sources of Minority Stress and Alcohol Consumption
少数群体压力和饮酒的内部根源
  • 批准号:
    10742318
  • 财政年份:
    2023
  • 资助金额:
    $ 24.44万
  • 项目类别:
Characterizing the Relationship Between Alcohol Consumption and Neuron-Derived Exosomal MicroRNA Cargo in an Adolescent-Young Adult Twin Cohort
青少年双胞胎队列中酒精消耗与神经元衍生的外泌体 MicroRNA 货物之间关系的表征
  • 批准号:
    10452928
  • 财政年份:
    2022
  • 资助金额:
    $ 24.44万
  • 项目类别:
Endocrine regulation of alcohol consumption and fear learning
饮酒和恐惧学习的内分泌调节
  • 批准号:
    10483780
  • 财政年份:
    2022
  • 资助金额:
    $ 24.44万
  • 项目类别:
The impact of friends sharing different modalities of alcohol-related social media content on alcohol consumption: A longitudinal examination of changes in content shared by social networks over time
朋友分享不同形式的酒精相关社交媒体内容对饮酒的影响:对社交网络分享内容随时间变化的纵向研究
  • 批准号:
    10534428
  • 财政年份:
    2022
  • 资助金额:
    $ 24.44万
  • 项目类别:
Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods
大麻对酒精消费的影响:整合实验室和生态瞬时评估方法
  • 批准号:
    10339931
  • 财政年份:
    2022
  • 资助金额:
    $ 24.44万
  • 项目类别:
Chronic alcohol consumption results in elevated Autotaxin levels that suppress anti-tumor immunity
长期饮酒会导致自分泌运动因子水平升高,从而抑制抗肿瘤免疫力
  • 批准号:
    10370159
  • 财政年份:
    2022
  • 资助金额:
    $ 24.44万
  • 项目类别:
Cannabis' Impact on Alcohol Consumption: Integrating Laboratory and Ecological Momentary Assessment Methods
大麻对酒精消费的影响:整合实验室和生态瞬时评估方法
  • 批准号:
    10595096
  • 财政年份:
    2022
  • 资助金额:
    $ 24.44万
  • 项目类别:
Technology-based assessments and intervention to reduce alcohol consumption and improve HIV viral suppression in the Florida Cohort
基于技术的评估和干预,以减少佛罗里达队列的饮酒量并改善艾滋病病毒抑制
  • 批准号:
    10707386
  • 财政年份:
    2022
  • 资助金额:
    $ 24.44万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了